NEFL and amyotrophic lateral sclerosis: Indeed, in human SBMA patients, plasma levels of neurofilament light chain, a well-established biomarker of neurodegeneration used in the devastating motor neuron disease amyotrophic lateral sclerosis, are not elevated, while serum levels of creatine kinase, a marker of cell autonomous muscle damage, are robustly elevated [27].